Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems.
paper
Cited
Public
Unavailable
- Authors
- Shippenberg, T S; Chefer, V I; Zapata, A; Heidbreder, C A
- Year
- 2001
- Journal
- Annals of the New York Academy of Sciences
- PMID
- 11458540
- DOI
- 10.1111/j.1749-6632.2001.tb03558.x
The repeated, intermittent use of cocaine and other drugs of abuse produces profound and often long-lasting alterations in behavior and brain chemistry. It has been suggested that these consequences of drug use play a critical role in drug craving and relapse to addiction. This article reviews the effects of psychostimulant administration on dopaminergic and excitatory amino acid neurotransmission in brain regions comprising the brain's motive circuit and provides evidence that the activation of endogenous kappa-opioid receptor systems in these regions opposes the behavioral and neurochemical consequences of repeated drug use. The role of this opioid system in mediating alterations in mood and affect that occur during abstinence from repeated psychostimulant use are also discussed.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence. | 2008 | 18319328 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Modulatory effects of orexin and dynorphin on stress-related alcohol seeking and relapse: pivotal role of the posterior paraventricular nucleus of the thalamus. | Holguin G et al. | β | 2026 | β |
| Triazole 187 is a biased KOR agonist that suppresses itch without sedation and induces anxiolytic-like behaviors in mice. | Volf A et al. | β | 2026 | β |
| Integrating Addiction Medicine Into Burn Care: Optimizing Pain Management in Stimulant-Positive Patients. | Stanton EW et al. | β | 2025 | β |
| KOR agonists for the treatment and/or prevention of opioid use disorder and cocaine use disorder. | Liu-Chen LY et al. | β | 2025 | β |
| Morphine-Induced Antinociception Is Potentiated and Dopamine Elevations Are Inhibited by the Biased Kappa Opioid Receptor Agonist Triazole 1.1. | Lopes EF et al. | β | 2025 | β |
| Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to self-administer cocaine and partially reverses dopamine system dysregulation. | Estave PM et al. | β | 2024 | β |
| Distinct Neuromodulatory Effects of Endogenous Orexin and Dynorphin Corelease on Projection-Defined Ventral Tegmental Dopamine Neurons. | Mohammadkhani A et al. | β | 2024 | β |
| Interaction between corticotropin-releasing factor, orexin, and dynorphin in the infralimbic cortex may mediate exacerbated alcohol-seeking behavior. | Flores-Ramirez FJ et al. | β | 2024 | β |
| Sex Differences in Brain Region-Specific Activation of c-Fos following Kappa Opioid Receptor Stimulation or Acute Stress in Mice. | Ma Q et al. | β | 2023 | β |
| Evaluation of the Intracellular Signaling Activities of ΞΊ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and Ξ²-Arrestin-Mediated Pathways. | Yamaguchi M et al. | β | 2022 | β |
| Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder. | Ragu Varman D et al. | β | 2022 | β |
| Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours. | Thomas CS et al. | β | 2022 | β |
| Effects of processed Aconiti tuber on the extinction and reinstatement of morphine-induced conditioned place preference in rats. | Wu G et al. | β | 2021 | β |
| Relevance of the Kappa Dynorphin System to Schizophrenia and Its Therapeutics. | Abi-Dargham A | β | 2021 | β |
| The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats. | Zamarripa CA et al. | β | 2021 | β |
| ΞΊ Opioid Receptor-Dynorphin Signaling in the Central Amygdala Regulates Conditioned Threat Discrimination and Anxiety. | Baird MA et al. | β | 2021 | β |
| The Therapeutic Potential of Novel Kappa Opioid Receptor-based Treatments. | Mercadante S et al. | β | 2020 | β |
| The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence. | Clark SD et al. | β | 2019 | β |
| Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated ΞΊ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor. | Dang DK et al. | β | 2018 | β |
| Opioid and hypocretin neuromodulation of ventral tegmental area neuronal subpopulations. | Thomas TS et al. | β | 2018 | β |
| Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction. | Karkhanis A et al. | β | 2017 | β |
| Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons. | Baimel C et al. | β | 2017 | β |
| Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. | Brust TF et al. | β | 2016 | β |
| Effects of the ΞΊ-opioid receptor on the inhibition of 100 Hz electroacupuncture on cocaine-induced conditioned place preference. | Hou B | β | 2016 | β |
| Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel Ξ²-arrestin-2-biased pathway. | Liu H et al. | β | 2016 | β |
| Increased expression of proenkephalin and prodynorphin mRNAs in the nucleus accumbens of compulsive methamphetamine taking rats. | Cadet JL et al. | β | 2016 | β |
| Methamphetamine potentiates HIV-1 gp120-mediated autophagy via Beclin-1 and Atg5/7 as a pro-survival response in astrocytes. | Cao L et al. | β | 2016 | β |
| A functional polymorphism in the prodynorphin gene affects cognitive flexibility and brain activation during reversal learning. | Votinov M et al. | β | 2015 | β |
| Placing the paraventricular nucleus of the thalamus within the brain circuits that control behavior. | Kirouac GJ | β | 2015 | β |
| Rewarding effects of electrical stimulation of the insular cortex: decayed effectiveness after repeated tests and subsequent increase in vertical behavioral activity and conditioned place aversion after naloxone administration. | GarcΓa R et al. | β | 2015 | β |
| Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum. | Oude Ophuis RJ et al. | β | 2014 | β |
| Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats. | Bonano JS et al. | β | 2014 | β |
| Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens. | Ehrich JM et al. | β | 2014 | β |
| Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor. | Ma J et al. | β | 2014 | β |
| Salvinorin A analogs and other ΞΊ-opioid receptor compounds as treatments for cocaine abuse. | Kivell BM et al. | β | 2014 | β |
| Dynorphin--still an extraordinarily potent opioid peptide. | Chavkin C | β | 2013 | β |
| The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats. | Morani AS et al. | β | 2013 | β |
| A single injection of a novel ΞΊ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats. | Morani AS et al. | β | 2012 | β |
| Effects of withdrawal from chronic escalating-dose binge cocaine on conditioned place preference to cocaine and striatal preproenkephalin mRNA in C57BL/6J mice. | Zhang Y et al. | β | 2012 | β |
| Zebrafish: a model for the study of addiction genetics. | Klee EW et al. | β | 2012 | β |
| Sex differences in kappa opioid pharmacology. | Rasakham K et al. | β | 2011 | β |
| Synthesis and biological evaluation of dibenz[b,f][1,5]oxazocine derivatives for agonist activity at ΞΊ-opioid receptor. | Mitra S et al. | β | 2011 | β |
| Nicotine withdrawal and kappa-opioid receptors. | McCarthy MJ et al. | β | 2010 | β |
| The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. | Wee S et al. | β | 2010 | β |
| Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats. | Baker LE et al. | β | 2009 | β |
| Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. | Wee S et al. | β | 2009 | β |
| Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse. | Prisinzano TE | β | 2009 | β |
| Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats. | Todtenkopf MS et al. | β | 2009 | β |
| Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors. | Fichna J et al. | β | 2009 | β |
| Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action. | Aldrich JV et al. | β | 2009 | β |
| Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens. | Xia YF et al. | β | 2008 | β |
| A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence. | Edenberg HJ et al. | β | 2008 | β |
| A unified framework for addiction: vulnerabilities in the decision process. | Redish AD et al. | β | 2008 | β |
| Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal. | Isola R et al. | β | 2008 | β |
| Purification and mass spectrometric analysis of the kappa opioid receptor. | Wannemacher KM et al. | β | 2008 | β |
| U-69593, a kappa opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats. | Puig-Ramos A et al. | β | 2008 | β |
| Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats. | Perreault ML et al. | β | 2007 | β |
| Dynorphin and the pathophysiology of drug addiction. | Shippenberg TS et al. | β | 2007 | β |
| Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships. | Katavic PL et al. | β | 2007 | β |
| Pharmacological and genetic manipulation of kappa opioid receptors: effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling. | Kaminski RM et al. | β | 2007 | β |
| Preprodynorphin mediates locomotion and D2 dopamine and mu-opioid receptor changes induced by chronic 'binge' cocaine administration. | Bailey A et al. | β | 2007 | β |
| Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. | Bruchas MR et al. | β | 2007 | β |
| An essential role for DeltaFosB in the nucleus accumbens in morphine action. | Zachariou V et al. | β | 2006 | β |
| Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. | Kuzmin A et al. | β | 2006 | β |
| Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. | Gerra G et al. | β | 2006 | β |
| Comparison of opioid receptor distributions in the rat central nervous system. | Gray AC et al. | β | 2006 | β |
| Endogenous kappa opioid receptor systems modulate the responsiveness of mesoaccumbal dopamine neurons to ethanol. | Zapata A et al. | β | 2006 | β |
| Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice. | MendizΓ‘bal V et al. | β | 2006 | β |
| Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms. | Perreault ML et al. | β | 2006 | β |
| Methamphetamine-induced behavioral sensitization in mice: alterations in mu-opioid receptor. | Chiu CT et al. | β | 2006 | β |
| Nalbuphine is effective in decreasing the rewarding effect induced by morphine in rats. | Tao PL et al. | β | 2006 | β |
| Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide. | Zeynalov E et al. | β | 2006 | β |
| Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. | Guerriero RM et al. | β | 2005 | β |
| Chronic cocaine injections attenuate behavioral response of kappa-opioid receptors to U-50,488H agonist. | Kudryavtseva NN et al. | β | 2005 | β |
| Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men. | Mello NK et al. | β | 2005 | β |
| Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. | Chefer VI et al. | β | 2005 | β |
| Ischemic neuroprotection with selective kappa-opioid receptor agonist is gender specific. | Chen CH et al. | β | 2005 | β |
| Kappa opioids as potential treatments for stimulant dependence. | Prisinzano TE et al. | β | 2005 | β |
| A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A. | Tidgewell K et al. | β | 2004 | β |
| Agents in development for the management of cocaine abuse. | Gorelick DA et al. | β | 2004 | β |
| Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats. | Chen TY et al. | β | 2004 | β |
| Expression of amphetamine-induced behavioral sensitization after short- and long-term withdrawal periods: participation of mu- and delta-opioid receptors. | Magendzo K et al. | β | 2003 | β |
| Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. | Margolis EB et al. | β | 2003 | β |
| Cocaine modulates mu-opioid receptor mRNA but not c-fos mRNA levels in primary cortical astrocytes. | Festa ED et al. | β | 2002 | β |
| Endogenous opiates and behavior: 2001. | Bodnar RJ et al. | β | 2002 | β |
| Involvement of kappa-opioid receptors in peripheral response to nerve stimulation in kappa-opioid receptor knockout mice. | Mitolo-Chieppa D et al. | β | 2002 | β |
| Neural systems underlying opiate addiction. | De Vries TJ et al. | β | 2002 | β |
| Peripheral electric stimulation attenuates the expression of cocaine-induced place preference in rats. | Ren YH et al. | β | 2002 | β |
| Endocrinological basis of sex differences in cocaine-induced behavioral responses. | QuiΓ±ones-Jenab V et al. | β | 2001 | β |